Henstridge D: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
|lastname=Henstridge | |lastname=Henstridge | ||
|firstname=Darren | |firstname=Darren | ||
|title= | |title=Dr. | ||
Senior Research Officer | |||
|institution=Cellular and Molecular Metabolism Laboratory | |institution=Cellular and Molecular Metabolism Laboratory | ||
| Line 16: | Line 17: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | == Participated at == | ||
*[[MiPNet21.04 IOC110 Melbourne AU | IOC110 Melbourne AU ]] | ::::*[[MiPNet21.04 IOC110 Melbourne AU | IOC110 Melbourne AU ]] | ||
Latest revision as of 12:12, 14 February 2018
| Name | Henstridge Darren, Dr.
Senior Research Officer |
|---|---|
| Institution | Cellular and Molecular Metabolism Laboratory
Division of Metabolism and Obesity Baker IDI Heart and Diabetes Institute |
| Address | 75 Commercial Road, 3004 |
| City | Melbourne |
| State/Province | |
| Country | Australia |
| Darren.Henstridge@bakeridi.edu.au | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Watt 2021 Nat Commun | 2021 | Watt KI, Henstridge DC, Ziemann M, Sim CB, Montgomery MK, Samocha-Bonet D, Parker BL, Dodd GT, Bond ST, Salmi TM, Lee RS, Thomson RE, Hagg A, Davey JR, Qian H, Koopman R, El-Osta A, Greenfield JR, Watt MJ, Febbraio MA, Drew BG, Cox AG, Porrello ER, Harvey KF, Gregorevic P (2021) Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease. Nat Commun 12:2887. |
Abstracts
| Published | Reference | |
|---|---|---|
| King 2017 ANDA2017 | 2017 | Improving skeletal muscle mitochondrial turnover to combat insulin resistance. |
